MESO Mesoblast ADRs

Mesoblast Ltd is engaged in the development of biologic products for the broad field of regenerative medicine. Its proprietary regenerative medicine technology platform is based on specialized cells known as mesenchymal lineage adult stem cells. This is an ADR of a company whose stock trades outside of the U.S. as the symbol AT:MSB.

$9.26  -0.34 (-3.54%)
As of 03/02/2021 15:57:58 EST     IEX book   CBOE book


Security Information
Category1:
Category2:
Category3:
GICS sector:
Industry:
Index country:
Country of incorporation:
IPO date:
Outstanding shares:
Average volume:
Market cap:
Current dividend yield:
All SEC filings:
Annual filings:
CUSIP:
ISIN:
Sedol:
US Equity
ADRs
Small cap
Health Care
Biotechnology
Australia
Australia
01/18/2006
117,517,356
602,948
$1,128,166,618
0.00%
SEC Edgar Online
20-F
590717104
US5907171046

Valuation   (See tab for details)
PE ratio:
PB ratio:
PS ratio:
Return on equity:
Net income %:
-11.63
2.17
68.74
-18.01%
-591.00%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy